Aspira Pathlab Promoter Jay Arvind Bhanushali Increases Stake via Open Market
Aspira Pathlab & Diagnostics Ltd 路 Acquisition/ Disposal of Shares 路 14 Nov 2026, 4:18 pm
Aspira Pathlab Promoter Jay Arvind Bhanushali Increases Stake via Open Market Promoter Jay Arvind Bhanushali acquired 1,289 equity shares (~0.01%) of Aspira Pathlab & Diagnostics Ltd via open market purchases on 12th Nov'26. Following this transaction, his total shareholding in the company increased from 7,49,507 equity shares (7.28%) to 7,50,796 equity shares (7.29%). The company's total equity share capital remains unchanged at Rs. 10.29 cr, comprising 1,02,93,000 equity shares of Rs. 10 each.
Original exchange filing (PDF)
More announcements from Aspira Pathlab & Diagnostics Ltd
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Arvind Bhanushali 路 14 Nov 2026
- Enclosed herewith Financial Result for the Half Year ended 30th September 2026 路 06 Nov 2026
- Enclosed herewith Board Meeting Outcomes dated 6th November 2026 路 06 Nov 2026
- Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2026 ,inter alia, to consider and approve Un-audited Financial .... 路 06 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Arvind Bhanushali 路 01 Oct 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Arvind Bhanushali 路 28 Sept 2026
- Disclosure of Voting Results of 53rd Annual General Meeting along with the Scrutinizer Report 路 26 Sept 2026
- Please find attached summary of proceeding /outcome of the 53rd Annual General Meeting of the Company held on Friday,25th September,2026 路 26 Sept 2026
